Old Videos2022-05-25T00:59:42-07:00

Videos

Videos

Featured Videos

Leveraging Highly Sensitive NGS Assays for Clonality, SHM and MRD Assessments

September 23rd, 2024|2024 Videos, Featured Videos, Videos|

PRESENTED BY
Presented by Katja Manninen, MS, MB(ASCP)CM - Field Applications Scientist at Invivoscribe, Inc.

Innovations in MRD Detection: Leveraging NGS to Gain Insights into Multiple Myeloma and B-ALL

September 17th, 2024|2024 Videos, Featured Videos, Videos|

PRESENTED BY
Presented by Prof. Myungshin Kim and Dr. Roisin McAvera, BSc (Hons), PhD

Unlocking the Potential of NGS Clonality and MRD Testing: From Research to High-Throughput Environments – Part 02

June 25th, 2024|2024 Videos, Featured Videos, Videos|

PRESENTED BY
Presented by Dr. Wayne Yu from Memorial Sloan Kettering Cancer Center

Unlocking the Potential of NGS Clonality and MRD Testing: From Research to High-Throughput Environments – Part 01

June 25th, 2024|2024 Videos, Featured Videos, Videos|

PRESENTED BY
Dr. Artur Kibler from the Institute of Cell Biology (Cancer Research) Medical Faculty, University of Duisburg-Essen

The Evolving Role of NGS and Measurable Residual Disease in CLL/SLL and AML

November 16th, 2023|2023 Videos, Featured Videos, Videos|

PRESENTED BY
Dr. Bevan Tandon, Chief Medical Officer of siParadigm Diagnostics Informatics and Dr. Jason Willis, Lead Hematopathologist of LabPMM (a wholly-owned subsidiary of Invivoscribe) at the AMP 2023 Annual Meeting & Expo

Latest Videos

Leveraging Highly Sensitive NGS Assays for Clonality, SHM and MRD Assessments

PRESENTED BY
Presented by Katja Manninen, MS, MB(ASCP)CM - Field Applications Scientist at Invivoscribe, Inc.

September 23rd, 2024|2024 Videos, Featured Videos, Videos|

Innovations in MRD Detection: Leveraging NGS to Gain Insights into Multiple Myeloma and B-ALL

PRESENTED BY
Presented by Prof. Myungshin Kim and Dr. Roisin McAvera, BSc (Hons), PhD

September 17th, 2024|2024 Videos, Featured Videos, Videos|

Unlocking the Potential of NGS Clonality and MRD Testing: From Research to High-Throughput Environments – Part 02

PRESENTED BY
Presented by Dr. Wayne Yu from Memorial Sloan Kettering Cancer Center

June 25th, 2024|2024 Videos, Featured Videos, Videos|

Unlocking the Potential of NGS Clonality and MRD Testing: From Research to High-Throughput Environments – Part 01

PRESENTED BY
Dr. Artur Kibler from the Institute of Cell Biology (Cancer Research) Medical Faculty, University of Duisburg-Essen

June 25th, 2024|2024 Videos, Featured Videos, Videos|

The Evolving Role of NGS and Measurable Residual Disease in CLL/SLL and AML

PRESENTED BY
Dr. Bevan Tandon, Chief Medical Officer of siParadigm Diagnostics Informatics and Dr. Jason Willis, Lead Hematopathologist of LabPMM (a wholly-owned subsidiary of Invivoscribe) at the AMP 2023 Annual Meeting & Expo

November 16th, 2023|2023 Videos, Featured Videos, Videos|

MRD Applications and Analysis

PRESENTED BY
Dr. Linda Lee from Royal North Shore Hospital and Dr. Irene Della Starza from Fondazione GIMEMA Franco Mandelli Onlus and Sapienza University, Rome

June 20th, 2023|2023 Videos, Featured Videos, Videos|

Lab Secrets: The Potential for NGS-based MRD Testing for Acute Lymphoblastic Leukemia – The Austin Experience

PRESENTED BY
Rishu Agarwal, MBBS PhD FRCPA and Stephen B. Ma, BBiomedSc BSc(Hone) MD DipMus LMus(dist) - Austin Health

November 15th, 2022|2022 Videos, 2022 Webinars, Featured Videos, Videos|

Development and Implementation of an Automated and Highly Accurate Reporting Process for NGS-based Clonality Testing

PRESENTED BY
Sean T. Glenn, PhD - Roswell Park Comprehensive Cancer Center

November 2nd, 2022|2022 Videos, 2022 Webinars, Featured Videos, Videos|

High-Throughput Sequencing of TCR Gene Rearrangements as a Useful Tool for Identifying and Tracking Minimal/Measurable Residual Disease (MRD) in Lymphoid Malignancies

PRESENTED BY
Jack Tung, MD, PhD - Stanford University

November 2nd, 2022|2022 Videos, 2022 Webinars, Featured Videos, Videos|

NGS-based Clinical Assessment of B- and T-cell Clonality and MRD Determination

PRESENTED BY
Dr. Alejandro Medina Herrera from University Hospital of Salamanca and Dr. Carolina Terragna from IRCCS – University Hospital of Bologna

October 26th, 2022|2022 Videos, 2022 Webinars, Featured Videos, Videos|

Corporate Overview

Invivoscribe is a technology-driven international company focused on precision diagnostics with best-in-class products and services that optimize patient care and accelerate drug approvals worldwide.

March 10th, 2022|2022 Videos, Featured Videos, Videos|

Lab Secrets: Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS)

FEATURED PRESENTERS
Riccardo Bomben, MD and Wouter De Brouwer, MD

February 24th, 2022|2022 Videos, Featured Videos, Videos|

Review of Guidelines for Interpreting Somatic Hypermutation Status in Chronic Lymphocytic Leukemia in the Era of High-Throughput Sequencing

FEATURED PRESENTERS
Dr. Siby Sebastian, PhD, DABMGG, DABCC, NYCOQ

January 26th, 2022|2022 Videos, Featured Videos, Videos|

Critical Mistakes to Avoid when Developing a Drug/CDx Combination for International Registrations

FEATURED PRESENTERS
Jason Gerhold / Global Director of Regulatory, Quality, and Clinical Affairs Invivoscribe, Inc.

August 24th, 2021|2021 Videos, Featured Videos, Videos|

Artificial Intelligence (AI) and other Data Science Applications in Molecular Pathology

FEATURED PRESENTER
Dr. Bradley Patay

November 16th, 2020|2020 Videos, Videos|

Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing

FEATURED PRESENTERS
Yury Monczak, Ph.D / Ryan J. Schmidt, MD, PhD

November 16th, 2020|2020 Videos, Videos|